EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of a nomogram to predict recurrence scores obtained using Oncotype DX in Japanese patients with breast cancer

Akio Shibata, Nobuko Tamura, Keiichi Kinowaki, Aya Nishikawa, Kiyo Tanaka, Yoko Kobayashi, Takuya Ogura, Yuko Tanabe, Hidetaka Kawabata

Breast Cancer · 2024

DOI: 10.1007/s12282-024-01616-z ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Cancer, 2024. Verfasst von Akio Shibata und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast and Endocrine Surgery, Toranomon Hospital, 2-2-2 Toranomon, Minato City, Tokyo, 105-8470, Japan. aki4107@gmail.com. Hauptthemen laut MEDLINE: Nomograms, Breast Neoplasms, Neoplasm Recurrence, Local, Erb-b2 Receptor Tyrosine Kinases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chemotherapy is crucial for hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer, and its survival benefits may outweigh adverse events. Oncotype DX (ODX) assesses this balance; however, it is expensive. Using nomograms to identify cases requiring ODX may be economically beneficial. We aimed to identify clinicopathological variables that correlated with the recurrence score (RS) and develop a nomogram that predicted the RS.

Methods

We included 457 patients with estrogen receptor-positive, HER2-negative breast cancer with metastases in fewer than four axillary lymph nodes who underwent surgery and ODX at our hospital between 2007 and 2023. We developed nomograms and internally validated them in 310 patients who underwent surgery between 2007 and 2021 and validated the model’s performance in 147 patients who underwent surgery between 2022 and 2023.

Results

Logistic regression analysis revealed that progesterone receptor (PgR) level, histological grade (HG), and Ki67 index independently predicted the RS. A nomogram was developed using these variables to predict the RS (area under the curve [AUC], 0.870; 95% confidence interval [CI], 0.82–0.92). The nomogram was applied to the model validation group (AUC, 0.877; 95% CI, 0.80–0.95). When the sensitivity of the nomogram was 90%, the model was able to identify 52.3% low-RS and 41.2% high-RS cases not requiring ODX.

Conclusions

This was the first nomogram model developed based on data from a cohort of Japanese women. It may help determine the indications for ODX and the use of nomogram to identify cases requiring ODX may be economically beneficial.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NomogramsBreast NeoplasmsNeoplasm Recurrence, LocalErb-b2 Receptor Tyrosine KinasesReceptors, EstrogenReceptors, ProgesteroneHumansFemaleMiddle AgedAgedAdultJapanBiomarkers, TumorLymphatic MetastasisAged, 80 and overKi-67 AntigenGene Expression ProfilingEast Asian People

Stichwörter der Autor:innen

Breast cancerNomogramOncotype DXPredictionRecurrence

Substanzen

Erb-b2 Receptor Tyrosine KinasesReceptors, EstrogenReceptors, ProgesteroneBiomarkers, TumorKi-67 AntigenERBB2 protein, human

Autor:innen und Institutionen

  • Department of Breast and Endocrine Surgery, Toranomon Hospital, 2-2-2 Toranomon, Minato City, Tokyo, 105-8470, Japan. aki4107@gmail.com.
  • Department of Breast and Endocrine Surgery, Toranomon Hospital, 2-2-2 Toranomon, Minato City, Tokyo, 105-8470, Japan.
  • Department of Pathology, Toranomon Hospital, Tokyo, Japan.
  • Department of Clinical Oncology, Toranomon Hospital, Tokyo, Japan.

Zitieren

APA

Shibata, A., Tamura, N., Kinowaki, K., Nishikawa, A., Tanaka, K., Kobayashi, Y., Ogura, T., Tanabe, Y., & Kawabata, H. (2024). Development of a nomogram to predict recurrence scores obtained using Oncotype DX in Japanese patients with breast cancer. Breast Cancer. https://doi.org/10.1007/s12282-024-01616-z

Vancouver

Shibata A, Tamura N, Kinowaki K, Nishikawa A, Tanaka K, Kobayashi Y, et al. Development of a nomogram to predict recurrence scores obtained using Oncotype DX in Japanese patients with breast cancer. Breast Cancer. 2024. doi:10.1007/s12282-024-01616-z

BibTeX
@article{Shibata2024,
  author = {Shibata, Akio and Tamura, Nobuko and Kinowaki, Keiichi and Nishikawa, Aya and Tanaka, Kiyo and Kobayashi, Yoko and Ogura, Takuya and Tanabe, Yuko and Kawabata, Hidetaka},
  title = {Development of a nomogram to predict recurrence scores obtained using Oncotype DX in Japanese patients with breast cancer},
  journal = {Breast Cancer},
  year = {2024},
  doi = {10.1007/s12282-024-01616-z}
}
Kostenlos starten →